When you have diabetes, your daily life revolves around one thing: blood sugar. Not just the number on your meter, but what it means for your body over weeks and months. Two tools dominate this reality: the A1C test and daily glucose monitoring. One tells you where you’ve been. The other shows you where you are right now. Together, they’re the backbone of managing diabetes-but only if you understand how to use them.
What A1C Really Tells You (And What It Doesn’t)
A1C isn’t a snapshot. It’s a movie. It shows your average blood sugar over the last 2 to 3 months by measuring how much glucose has stuck to your red blood cells. Normal is under 5.7%. Prediabetes is 5.7% to 6.4%. Diabetes? 6.5% or higher. That’s the standard set by the CDC and ADA since 2010.
But here’s the catch: A1C doesn’t show spikes or crashes. Two people can have the same A1C of 7%, but one spends 12 hours a day above 200 mg/dL and the other swings wildly between 50 and 250 mg/dL. Both have the same number. Only one is in real danger.
That’s why A1C alone can be misleading. It doesn’t tell you about hypoglycemia, especially if you’re unaware of it. And it’s wrong for some people. If you have anemia, kidney disease, or certain hemoglobin variants (common in African, Mediterranean, or Southeast Asian populations), your A1C can be artificially high or low. A 2022 study showed that for some, A1C can be off by more than 1%-that’s a full category shift in risk.
What Are the Right A1C Targets?
There’s no single number that fits everyone. That’s the big shift in diabetes care over the last decade.
The American Diabetes Association says most nonpregnant adults should aim for under 7%. But they also say: individualize it. That means your target could be 6.5% if you’re young, healthy, and not prone to lows. Or 8% if you’re older, have heart disease, or have had severe hypoglycemia.
The American College of Physicians (ACP) says 7% to 8% is enough for most people with type 2 diabetes. Why? Because studies like ACCORD showed that pushing below 6.5% didn’t lower heart attacks or deaths-but it did increase hypoglycemia, weight gain, and even death risk in some groups.
Meanwhile, the American Association of Clinical Endocrinologists (AACE) still pushes for 6.5% if it’s safe. And in the UK, NICE guidelines say 6.5% for new type 2 patients on one medication, 7% if you’re on multiple drugs.
Here’s the truth: guidelines are tools, not rules. Your doctor’s job isn’t to hit a number. It’s to help you live well-without passing out from low blood sugar or ending up in the ER.
Daily Glucose Monitoring: Fingersticks vs. CGMs
While A1C looks backward, daily monitoring looks forward. You have two main options: fingerstick meters and continuous glucose monitors (CGMs).
Fingerstick meters are simple. You prick your finger, put a drop of blood on a strip, and get a number in seconds. They’re accurate within ±15 mg/dL. But they’re snapshots. If you only test before meals, you miss what happens after eating, during sleep, or after stress. And most people don’t test enough. Medicare covers 100 strips a month for insulin users-but many still ration them because of cost.
CGMs are different. Devices like Dexcom G7 and Abbott FreeStyle Libre 3 measure glucose in your interstitial fluid every 5 minutes. They don’t need fingersticks for calibration (though you still need them to confirm low readings). They show trends: rising, falling, flat. They alert you when you’re dropping too fast. They let you see how your coffee, walk, or stress affects your numbers in real time.
By 2022, 58% of insulin users in the U.S. used CGMs. That’s up from 15% in 2017. But only 22% of type 2 patients use them-even though they benefit too. Why? Cost. Even with Medicare covering them, out-of-pocket costs can hit $127 a month. And if you’re on Medicaid, 32% report rationing strips or skipping sensors because they can’t afford them.
Time-in-Range: The New Gold Standard
CGMs gave us something A1C never could: time-in-range (TIR). That’s the percentage of time your glucose stays between 70 and 180 mg/dL.
The ADA now says most adults should aim for TIR over 70%. That means less than 4% of your day below 70 mg/dL and under 1% below 54 mg/dL. Why? Because studies show that 70% TIR matches up with an A1C of about 7%. But it also tells you if you’re safe.
One user on Reddit said: “My A1C is 6.8%. But my CGM shows I’m under 60 mg/dL three times a week. My doctor still says I’m doing great.” That’s not great. That’s dangerous. TIR catches what A1C hides.
And it’s actionable. If your glucose spikes after pasta, you can change your meal. If it drops overnight, you can adjust your insulin. You’re not guessing anymore. You’re responding.
Real People, Real Struggles
Guidelines don’t live in clinics. They live in kitchens, cars, and bedrooms.
One 70-year-old woman with type 2 diabetes had her target raised from 7% to 8% after a hypoglycemic episode left her confused and hospitalized. “I stopped fearing my meter,” she told a forum. “I started living.”
Another, diagnosed with type 1 at age 12, said: “My endo wants 6.5%. But I’ve had two ER visits for lows in a year. I’m not going back.” She now targets 7.5% and uses CGM alerts. Her quality of life improved. Her A1C? 7.2%.
And then there’s the financial reality. A 2022 study found 34% of low-income patients couldn’t afford recommended supplies. That’s not a personal failure. It’s a system failure. No amount of education helps if you can’t buy the strips.
How to Make This Work for You
Here’s what actually helps:
- Match your testing to your treatment. If you’re on insulin, test 4-10 times a day. If you’re on metformin alone, 1-2 times a day may be enough.
- Use CGM if you can. Even if you’re not on insulin. Seeing your patterns reduces guesswork and anxiety.
- Ask for your A1C and TIR together. Don’t settle for just one number. Ask: “What’s my time-in-range? How much time am I spending below 70?”
- Don’t let A1C be your only goal. If you’re having lows, your target should be higher-not lower.
- Get educated. Two to four sessions with a certified diabetes educator can turn confusion into confidence. One study found 78% of people mastered pattern recognition after just three sessions.
What’s Next?
The future is personal. The ADA is now pushing to include social factors-like income, food access, and stress-into target-setting algorithms. Google and Dexcom are working on a contact lens that measures glucose. Non-invasive tech is coming.
But right now, the best tool you have is knowledge. Know your numbers. Know your body. Know your limits. A1C is a guide. CGM is your compass. Together, they don’t just manage diabetes-they help you live with it, not for it.
What A1C level is considered normal?
A normal A1C level is below 5.7%. Between 5.7% and 6.4% is prediabetes, and 6.5% or higher on two separate tests means diabetes. These thresholds were set by the CDC and ADA in 2010 and remain the standard today.
Is an A1C of 7% good for everyone with diabetes?
No. While 7% is often used as a general goal, it’s not right for everyone. For younger, healthier people, aiming lower (like 6.5%) may reduce long-term complications. For older adults, those with heart disease, or people prone to low blood sugar, a target of 7.5% to 8% is safer and more realistic. The goal is balance-lower risk of complications without risking dangerous lows.
How accurate are continuous glucose monitors (CGMs)?
Modern CGMs like Dexcom G7 and FreeStyle Libre 3 are very accurate. They’re typically within ±9 mg/dL for readings under 100 mg/dL and within ±9% for higher readings. That’s better than most fingerstick meters. But they still need occasional fingerstick checks to confirm when your glucose is low or rising fast. CGMs measure fluid between cells, not blood directly, so there’s a slight delay.
Can I rely on A1C alone to manage my diabetes?
No. A1C gives you a 3-month average, but it hides dangerous spikes and drops. Someone with an A1C of 7% could be spending hours below 60 mg/dL or above 250 mg/dL. That’s why daily monitoring with CGMs or frequent fingersticks is essential. Time-in-range (70-180 mg/dL) is now considered a more useful daily metric than A1C alone.
Why do some doctors recommend higher A1C targets?
Because aggressive lowering can be harmful. Studies like ACCORD showed that pushing A1C below 6.5% increased the risk of severe hypoglycemia, weight gain, and even death in some older or high-risk patients. For people with limited life expectancy, multiple health issues, or a history of lows, a higher target (7-8%) reduces immediate risks and improves quality of life. The goal isn’t perfection-it’s safety and sustainability.
How often should I get my A1C tested?
If your diabetes is stable and you’re meeting your goals, test twice a year. If you’ve changed your treatment, started insulin, or aren’t hitting targets, test every 3 months. Point-of-care tests at your doctor’s office give results in minutes, while lab tests take 1-3 days.
Are CGMs covered by insurance?
Yes, in most cases. Medicare covers CGMs for all insulin-requiring patients. Many private insurers cover them too, especially if you have frequent lows or unstable blood sugar. Some require proof you’re on insulin or have hypoglycemia unawareness. Coverage for non-insulin users is expanding, with CMS proposing coverage for type 2 patients with frequent lows as of 2023.
What if I can’t afford glucose test strips or CGMs?
You’re not alone. About 34% of low-income patients can’t afford recommended supplies. Talk to your doctor-they may have samples, manufacturer coupons, or connections to nonprofit programs. Some brands offer free starter kits. Medicaid expansion and patient assistance programs can help. Never ration strips if you’re on insulin-low blood sugar can be life-threatening. Ask for help; you deserve to manage your health safely.
Comments(12)